Adam Stenman
Overview
Explore the profile of Adam Stenman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
837
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lundgren Mortensen A, Berglund H, Jha P, Stenman A, Selvaraju R, Lundqvist H, et al.
Mol Cancer Ther
. 2025 Feb;
PMID: 39976160
Anaplastic thyroid cancer (ATC) is a rare but severe form of thyroid cancer responsible for approximately 50% of thyroid cancer deaths. Consequently, the identification of innovative therapies remains crucial for...
2.
Bentzen M, Kentta G, Derman W, Halvorsen Wik E, Havela J, Karls T, et al.
BMJ Open Sport Exerc Med
. 2025 Feb;
11(1):e002267.
PMID: 39949565
Background: The interest in elite athletes' mental health has increased over the past decade. However, there is still a paucity in the literature concerning elite Para athletes' mental health and...
3.
Hellgren L, Stenman A, Jatta K, Condello V, Larsson C, Zedenius J, et al.
Endocr Pathol
. 2024 Oct;
35(4):411-418.
PMID: 39363120
De-escalation of thyroid cancer treatment is crucial to prevent overtreatment of indolent disease, but it remains important to identify clinically aggressive cases. TERT promoter mutations are molecular events frequently associated...
4.
Svahn F, Solhuslokk Hose K, Stenman A, Liu Y, Calissendorff J, Tham E, et al.
Endocr Relat Cancer
. 2024 Jun;
31(9).
PMID: 38864697
Pheochromocytoma (PCC) and abdominal paraganglioma (aPGL) (together abbreviated PPGL) frequently present with an underlying genetic event in a PPGL driver gene, and additional susceptibility genes are anticipated. Here, we re-analyzed...
5.
Condello V, Roberts J, Stenman A, Larsson C, Viswanathan K, Juhlin C
Virchows Arch
. 2024 Apr;
485(1):105-114.
PMID: 38637342
Somatic and biallelic DICER1 mutations are reported in subsets of thyroid tumors, supporting the role of this gene in thyroid tumor development. As recent studies have brought attention to macrofollicular...
6.
Falhammar H, Stenman A, Juhlin C, Kistner A
Endocrine
. 2024 Apr;
85(1):356-362.
PMID: 38581593
Purpose: To study the prevalence of primary adrenal tumors and adrenal metastases in patients with neuroendocrine neoplasms (NENs) and describe these in detail. NENs can be further divided into neuroendocrine...
7.
Stenman A, Juhlin C
Cancers (Basel)
. 2023 Sep;
15(18).
PMID: 37760590
Anaplastic thyroid carcinoma (ATC) stands as a rare but extraordinarily lethal tumor, marked by its limited treatment options [...].
8.
Stenman A, Falhammar H, Zedenius J, Juhlin C
Endocrine
. 2023 Aug;
82(3):631-637.
PMID: 37535242
Purpose: Adrenal schwannoma (AS) and periadrenal schwannoma (PAS) are exceedingly rare Schwann cell tumors that develop from the adrenal medulla and periadrenal peripheral nerves respectively. The underlying genetic events are...
9.
Stenman A, Zedenius J, Juhlin C
Lakartidningen
. 2023 Apr;
120.
PMID: 37052304
Adrenohepatic fusion (AHF) is a union of the right adrenal gland and the liver with intermingling of parenchymal adrenal and liver cells. The phenomenon can be of clinical importance when...
10.
Hysek M, Hellgren L, Stenman A, Darai-Ramqvist E, Ljung E, Schliemann I, et al.
Diagn Cytopathol
. 2023 Mar;
51(6):331-340.
PMID: 36870048
Background: Despite the advent of comprehensive molecular testing in surgical pathology, most centers still rely on the morphological assessment of fine-needle aspiration cytology (FNAC) to triage patients with thyroid nodules...